Filter
25
Text search:
Charité
Featured
Recommendations
6
New Publications
8
Language
Document type
No document type
10
Guidelines
5
Studies & Reports
3
Brochures
2
Online Courses
2
Videos
1
Strategic & Response Plan
1
Fact sheets
1
Countries / Regions
Germany
6
Brazil
2
Guinea-Bissau
1
Uganda
1
Zimbabwe
1
Haiti
1
Iraq
1
Syria
1
South Africa
1
Malawi
1
Mozambique
1
Benin
1
Angola
1
Madagascar
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
6
Public Health
1
Clinical Guidelines
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
11
Refugee
3
Global Health Education
2
Ebola
1
NCDs
1
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-
...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é
...
The article outlines the prioritized research agenda for the prevention and control of chronic respiratory diseases (CRDs) as part of the World Health Organization's (WHO) action plan on noncommunicable diseases (NCDs) from 2008 to 2013. It highlights the significant global impact of CRDs, including
...
